Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
83.63
+4.56 (5.76%)
At close: Feb 10, 2026, 4:00 PM EST
82.12
-1.50 (-1.80%)
After-hours: Feb 10, 2026, 6:48 PM EST

Spruce Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-47.88-53.04-47.92-46.18-42.29-29.54
Depreciation & Amortization
0.030.050.070.070.070.04
Loss (Gain) From Sale of Assets
-000.04--
Loss (Gain) From Sale of Investments
---0.640.020.12-
Stock-Based Compensation
1.845.354.623.633.960.76
Other Operating Activities
-0.250.250.23-0.40.310.07
Change in Accounts Payable
-0.41-2.041.91-1.4-0.813.73
Change in Unearned Revenue
-0.7-4.914.91---
Change in Other Net Operating Assets
-0.17-1.623.542.532.76-2.57
Operating Cash Flow
-47.55-55.96-33.28-41.68-35.88-27.52
Capital Expenditures
---0.01-0.01-0.09-0.07
Investment in Securities
--55.7823.7-79.08-
Investing Cash Flow
--55.7823.69-79.17-0.07
Long-Term Debt Issued
----5-
Long-Term Debt Repaid
--1.62-1.62--4.77-
Net Debt Issued (Repaid)
-1.62-1.62-1.62-0.23-
Issuance of Common Stock
0.020.2553.790.080.4693.4
Repurchase of Common Stock
-0.23-0.25-0.31-0.04--
Other Financing Activities
---2.72-0.28-0.05-
Financing Cash Flow
-1.84-1.6249.14-0.240.64181.04
Net Cash Flow
-49.39-57.5971.64-18.23-114.4153.44
Free Cash Flow
-47.55-55.96-33.28-41.69-35.97-27.59
Free Cash Flow Margin
-6821.81%-1139.56%-329.88%---
Free Cash Flow Per Share
-81.91-101.72-64.82-132.90-115.48-345.42
Cash Interest Paid
0.230.230.370.270.210.19
Levered Free Cash Flow
-30.86-38.75-17.52-25.55-20.7-16.48
Unlevered Free Cash Flow
-30.77-38.56-17.22-25.28-20.49-16.28
Change in Working Capital
-1.28-8.5710.361.131.961.16
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.